BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reimer P, Jähnke N, Fiebich M, Schima W, Deckers F, Marx C, Holzknecht N, Saini S. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology. 2000;217:152-158. [PMID: 11012438 DOI: 10.1148/radiology.217.1.r00oc31152] [Cited by in Crossref: 141] [Cited by in F6Publishing: 122] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Bruegel M, Gaa J, Waldt S, Woertler K, Holzapfel K, Kiefer B, Rummeny EJ. Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences. AJR Am J Roentgenol. 2008;191:1421-1429. [PMID: 18941080 DOI: 10.2214/ajr.07.3279] [Cited by in Crossref: 108] [Cited by in F6Publishing: 29] [Article Influence: 7.7] [Reference Citation Analysis]
2 Chan VO, Das JP, Gerstenmaier JF, Geoghegan J, Gibney RG, Collins CD, Skehan SJ, Malone DE. Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist®)-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre. Ir J Med Sci 2012;181:499-509. [DOI: 10.1007/s11845-012-0805-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kim TJ, Lee KH, Kim YH, Sung SW, Jheon S, Cho S, Lee KW. Postoperative Imaging of Esophageal Cancer: What Chest Radiologists Need to Know. RadioGraphics 2007;27:409-29. [DOI: 10.1148/rg.272065034] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
4 Vyalikh A, Wolter AU, Hampel S, Haase D, Ritschel M, Leonhardt A, Grafe H, Taylor A, Krämer K, Büchner B, Klingeler R. A carbon-wrapped nanoscaled thermometer for temperature control in biological environments. Nanomedicine 2008;3:321-7. [DOI: 10.2217/17435889.3.3.321] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
5 Lin KY, Kwong GA, Warren AD, Wood DK, Bhatia SN. Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis. ACS Nano. 2013;7:9001-9009. [PMID: 24015809 DOI: 10.1021/nn403550c] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 7.6] [Reference Citation Analysis]
6 Wang YX. Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. Quant Imaging Med Surg 2011;1:35-40. [PMID: 23256052 DOI: 10.3978/j.issn.2223-4292.2011.08.03] [Cited by in F6Publishing: 226] [Reference Citation Analysis]
7 Coenegrachts K, Orlent H, ter Beek L, Haspeslagh M, Bipat S, Stoker J, Rigauts H. Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI. J Magn Reson Imaging. 2008;27:117-124. [PMID: 18050350 DOI: 10.1002/jmri.21247] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
8 Yang DM, Jahng GH, Kim HC, Jin W, Ryu CW, Nam DH, Lee YK, Park SY. The detection and discrimination of malignant and benign focal hepatic lesions: T2 weighted vs diffusion-weighted MRI. Br J Radiol. 2011;84:319-326. [PMID: 20959371 DOI: 10.1259/bjr/50130643] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
9 Fukukura Y, Kamiyama T, Takumi K, Shindo T, Higashi R, Nakajo M. Comparison of ferucarbotran-enhanced fluid-attenuated inversion-recovery echo-planar, T2-weighted turbo spin-echo, T2*-weighted gradient-echo, and diffusion-weighted echo-planar imaging for detection of malignant liver lesions. J Magn Reson Imaging 2010;31:607-16. [PMID: 20187203 DOI: 10.1002/jmri.22098] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Hussain SM, Semelka RC. Liver masses. Magn Reson Imaging Clin N Am. 2005;13:255-275. [PMID: 15935311 DOI: 10.1016/j.mric.2005.03.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
11 Scharitzer M, Schima W, Schober E, Reimer P, Helmberger TK, Holzknecht N, Stadler A, Ba-ssalamah A, Weber M, Wrba F. Characterization of Hepatocellular Tumors: Value of Mangafodipir-Enhanced Magnetic Resonance Imaging. Journal of Computer Assisted Tomography 2005;29:181-90. [DOI: 10.1097/01.rct.0000156397.51640.a1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
12 Mori K, Takahashi N, Hiratsuka M, Shiigai M, Minami M, Oda T, Ohkohchi N, Morishita Y. Detection of hepatic metastases using ferucarbotran-enhanced MR imaging: Feasibility and diagnostic accuracy of three-dimensional sensitivity-encoding water-excitation multishot echo-planar sequence (3D-SWEEP). J Magn Reson Imaging 2006;24:1110-6. [DOI: 10.1002/jmri.20755] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
13 Yu MK, Park J, Jon S. Magnetic nanoparticles and their applications in image-guided drug delivery. Drug Deliv and Transl Res 2012;2:3-21. [DOI: 10.1007/s13346-011-0049-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
14 Morana G, Salviato E, Guarise A. Contrast agents for hepatic MRI. Cancer Imaging 2007;7 Spec No A:S24-7. [PMID: 17921081 DOI: 10.1102/1470-7330.2007.9001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
15 Sica GT, Ji H, Ros PR. Computed tomography and magnetic resonance imaging of hepatic metastases. Clin Liver Dis 2002;6:165-79, vii. [PMID: 11933587 DOI: 10.1016/s1089-3261(03)00071-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
16 Kim YK, Ko SW, Hwang SB, Kim CS, Yu HC. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur Radiol. 2006;16:1337-1345. [PMID: 16453115 DOI: 10.1007/s00330-005-0140-y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
17 Okasha HH, Wifi MN, Awad A, Abdelfatah Y, Abdelfatah D, El-Sawy SS, Alzamzamy A, Abou-Elenin S, Abou-Elmagd A, ElHusseiny R, Wahba M, El-Feki MA, Pawlak KM. Role of EUS in detection of liver metastasis not seen by computed tomography or magnetic resonance imaging during staging of pancreatic, gastrointestinal, and thoracic malignancies. Endosc Ultrasound 2021;10:344-54. [PMID: 34558421 DOI: 10.4103/EUS-D-20-00178] [Reference Citation Analysis]
18 Halavaara J, Breuer J, Ayuso C, Balzer T, Bellin MF, Blomqvist L, Carter R, Grazioli L, Hammerstingl R, Huppertz A. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trial. J Comput Assist Tomogr. 2006;30:345-354. [PMID: 16778605 DOI: 10.1097/00004728-200605000-00001] [Cited by in Crossref: 142] [Cited by in F6Publishing: 125] [Article Influence: 8.9] [Reference Citation Analysis]
19 Lee HY, Lee JM, Kim SH, Shin KS, Lee JY, Han JK, Choi BI. Detection and characterization of focal hepatic lesions: comparative study of MDCT and gadobenate dimeglumine-enhanced MR imaging. Clin Imaging 2008;32:287-95. [PMID: 18603184 DOI: 10.1016/j.clinimag.2007.11.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
20 Kim SH, Choi D, Kim SH, Lim JH, Lee WJ, Kim MJ, Lim HK, Lee SJ. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2005;184:1069-1076. [PMID: 15788575 DOI: 10.2214/ajr.184.4.01841069] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
21 Matsuo M, Kanematsu M, Itoh K, Murakami T, Maetani Y, Kondo H, Goshima S, Kako N, Hoshi H, Konishi J, Moriyama N, Nakamura H. Detection of malignant hepatic tumors with ferumoxides-enhanced MRI: comparison of five gradient-recalled echo sequences with different TEs. AJR Am J Roentgenol 2004;182:235-42. [PMID: 14684545 DOI: 10.2214/ajr.182.1.1820235] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
22 Yoshikawa T, Mitchell DG, Hirota S, Ohno Y, Oda K, Maeda T, Fujii M, Sugimura K. Gradient- and spin-echo T2-weighted imaging for SPIO-enhanced detection and characterization of focal liver lesions. J Magn Reson Imaging 2006;23:712-9. [DOI: 10.1002/jmri.20572] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
23 Valls C, Martínez L, Ruiz S, Alba E. Radiological Imaging of Liver Metastases. In: Vauthey J, Hoff PM, Audisio RA, Poston GJ, editors. Liver Metastases. London: Springer; 2009. pp. 1-13. [DOI: 10.1007/978-1-84628-947-7_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Guggenheim EJ, Rappoport JZ, Lynch I. Mechanisms for cellular uptake of nanosized clinical MRI contrast agents. Nanotoxicology 2020;14:504-32. [PMID: 32037933 DOI: 10.1080/17435390.2019.1698779] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
25 Rosenberger I, Schmithals C, Vandooren J, Bianchessi S, Milani P, Locatelli E, Israel LL, Hübner F, Matteoli M, Lellouche JP, Franchini MC, Passoni L, Scanziani E, Opdenakker G, Piiper A, Kreuter J. Physico-chemical and toxicological characterization of iron-containing albumin nanoparticles as platforms for medical imaging. J Control Release 2014;194:130-7. [PMID: 25173842 DOI: 10.1016/j.jconrel.2014.08.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
26 Chou CT, Chen RC, Chen WT, Lii JM. Detection of hepatocellular carcinoma by ferucarbotran-enhanced magnetic resonance imaging: the efficacy of accumulation phase fat-suppressed T1-weighted imaging. Clin Radiol 2009;64:22-9. [PMID: 19070694 DOI: 10.1016/j.crad.2008.07.010] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
27 Stroszczynski C, Hunerbein M. Malignant biliary obstruction: value of imaging findings. Abdom Imaging 2005;30:314-24. [DOI: 10.1007/s00261-004-0251-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
28 Hsu F, Sun R, Hsieh C. Cellular Magnetic Resonance Imaging with Superparamagnetic Iron Oxide: Methods and Applications in Cancer. SPIN 2019;09:1940007. [DOI: 10.1142/s2010324719400071] [Reference Citation Analysis]
29 Li S, Beheshti M, Peck-Radosavljevic M, Oezer S, Grumbeck E, Schmid M, Hamilton G, Kapiotis S, Dudczak R, Kletter K. Comparison of (11)C-acetate positron emission tomography and (67)Gallium citrate scintigraphy in patients with hepatocellular carcinoma. Liver Int 2006;26:920-7. [PMID: 16953831 DOI: 10.1111/j.1478-3231.2006.01335.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
30 Thorek DLJ, Chen AK, Czupryna J, Tsourkas A. Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging. Ann Biomed Eng 2006;34:23-38. [DOI: 10.1007/s10439-005-9002-7] [Cited by in Crossref: 537] [Cited by in F6Publishing: 461] [Article Influence: 33.6] [Reference Citation Analysis]
31 Chang JM, Lee JM, Lee MW, Choi JY, Kim SH, Lee JY, Han JK, Choi BI. Superparamagnetic iron oxide-enhanced liver magnetic resonance imaging: comparison of 1.5 T and 3.0 T imaging for detection of focal malignant liver lesions. Invest Radiol. 2006;41:168-174. [PMID: 16428988 DOI: 10.1097/01.rli.0000192417.33989.7a] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
32 Cheng Z, Yan X, Sun X, Shen B, Gambhir SS. Tumor Molecular Imaging with Nanoparticles. Engineering 2016;2:132-40. [DOI: 10.1016/j.eng.2016.01.027] [Cited by in Crossref: 21] [Article Influence: 3.5] [Reference Citation Analysis]
33 Kehagias DT, Gouliamos AD, Smyrniotis V, Vlahos LJ. Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A). J Magn Reson Imaging 2001;14:595-601. [DOI: 10.1002/jmri.1224] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
34 Wersebe A, Wiskirchen J, Decker U, Schick F, Dietz K, M??ller-schimpfle M, Claussen CD, Pereira PL. Comparison of Gadolinium-BOPTA and Ferucarbotran-Enhanced Three-Dimensional T1-Weighted Dynamic Liver Magnetic Resonance Imaging in the Same Patient: . Investigative Radiology 2006;41:264-71. [DOI: 10.1097/01.rli.0000188359.72928.0f] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
35 Hussain SM, Semelka RC. Hepatic imaging: comparison of modalities. Radiol Clin North Am. 2005;43:929-947, ix. [PMID: 16098348 DOI: 10.1016/j.rcl.2005.05.006] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
36 Yang X. Nano- and microparticle-based imaging of cardiovascular interventions: overview. Radiology 2007;243:340-7. [PMID: 17456865 DOI: 10.1148/radiol.2432060307] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
37 Higashihara H, Murakami T, Kim T, Hori M, Onishi H, Nakata S, Osuga K, Tomoda K, Nakamura H. Differential diagnosis between metastatic tumors and nonsolid benign lesions of the liver using ferucarbotran-enhanced MR imaging. European Journal of Radiology 2010;73:125-30. [DOI: 10.1016/j.ejrad.2008.09.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
38 Leoni S, Piscaglia F, Golfieri R, Camaggi V, Vidili G, Pini P, Bolondi L. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol. 2010;105:599-609. [PMID: 19935786 DOI: 10.1038/ajg.2009.654] [Cited by in Crossref: 136] [Cited by in F6Publishing: 126] [Article Influence: 10.5] [Reference Citation Analysis]
39 Donati OF, Hany TF, Reiner CS, von Schulthess GK, Marincek B, Seifert B, Weishaupt D. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI. J Nucl Med. 2010;51:692-699. [PMID: 20395324 DOI: 10.2967/jnumed.109.068510] [Cited by in Crossref: 105] [Cited by in F6Publishing: 86] [Article Influence: 8.8] [Reference Citation Analysis]
40 Kim KW, Kim AY, Kim TK, Park SH, Kim HJ, Lee YK, Park M, Ha HK, Kim PN, Kim JC, Lee M. Small (≤ 2 cm) Hepatic Lesions in Colorectal Cancer Patients: Detection and Characterization on Mangafodipir Trisodium–Enhanced MRI. American Journal of Roentgenology 2004;182:1233-40. [DOI: 10.2214/ajr.182.5.1821233] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
41 Mazumdar M. Group sequential design for comparative diagnostic accuracy studies: implications and guidelines for practitioners. Med Decis Making 2004;24:525-33. [PMID: 15359002 DOI: 10.1177/0272989X04269240] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
42 He L, Zhang Y, Chen J, Liu G, Zhu J, Li X, Li D, Yang Y, Lee CS, Shi J, Yin C, Lai P, Wang L, Fang C. A multifunctional targeted nanoprobe with high NIR-II PAI/MRI performance for precise theranostics of orthotopic early-stage hepatocellular carcinoma. J Mater Chem B 2021;9:8779-92. [PMID: 34635903 DOI: 10.1039/d1tb01729b] [Reference Citation Analysis]
43 Lartigue L, Oumzil K, Guari Y, Larionova J, Guérin C, Montero J, Barragan-montero V, Sangregorio C, Caneschi A, Innocenti C, Kalaivani T, Arosio P, Lascialfari A. Water-Soluble Rhamnose-Coated Fe 3 O 4 Nanoparticles. Org Lett 2009;11:2992-5. [DOI: 10.1021/ol900949y] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
44 Zheng WW, Zhou KR, Chen ZW, Shen JZ, Chen CZ, Zhang SJ. Characterization of focal hepatic lesions with SPIO-enhanced MRI. World J Gastroenterol 2002; 8(1): 82-86 [PMID: 11833077 DOI: 10.3748/wjg.v8.i1.82] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
45 Kim MJ, Kim JH, Lim JS, Oh YT, Chung JJ, Choi JS, Lee WJ, Kim KW. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging 2004;20:612-21. [PMID: 15390224 DOI: 10.1002/jmri.20174] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
46 Bangard C, Stippel DL, Berg F, Kasper HU, Hellmich M, Fischer JH, Hölscher A, Lackner K, Gossmann A. Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: Comparison of an extracellular and an SPIO contrast agent. J Magn Reson Imaging 2008;28:263-70. [DOI: 10.1002/jmri.21423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
47 Ward J. Use of contrast agents for liver MRI. Radiography 2007;13:e54-72. [DOI: 10.1016/j.radi.2006.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
48 Weinmann HJ, Ebert W, Misselwitz B, Schmitt-Willich H. Tissue-specific MR contrast agents. Eur J Radiol 2003;46:33-44. [PMID: 12648800 DOI: 10.1016/s0720-048x(02)00332-7] [Cited by in Crossref: 192] [Cited by in F6Publishing: 31] [Article Influence: 10.1] [Reference Citation Analysis]
49 von Falkenhausen M, Meyer C, Lutterbey G, Morakkabati N, Walter O, Gieseke J, Blömer R, Willinek WA, Kuhl CK, Schild HH. Intra-individual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T. Eur Radiol 2007;17:1256-61. [PMID: 17171512 DOI: 10.1007/s00330-006-0484-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
50 Bluemke DA, Weber TM, Rubin D, de Lange EE, Semelka R, Redvanly RD, Chezmar J, Outwater E, Carlos R, Saini S, Holland GA, Mammone JF, Brown JJ, Milestone B, Javitt MC, Jacobs P. Hepatic MR Imaging with Ferumoxides: Multicenter Study of Safety and Effectiveness of Direct Injection Protocol. Radiology 2003;228:457-64. [DOI: 10.1148/radiol.2282012061] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
51 Motosugi U, Ichikawa T, Nakajima H, Sou H, Sano M, Sano K, Araki T, Iino H, Fujii H, Nakazawa T. Imaging of small hepatic metastases of colorectal carcinoma: how to use superparamagnetic iron oxide-enhanced magnetic resonance imaging in the multidetector-row computed tomography age? J Comput Assist Tomogr 2009;33:266-72. [PMID: 19346857 DOI: 10.1097/RCT.0b013e31817f5c82] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
52 Mori K, Scheidler J, Helmberger T, Holzknecht N, Schauer R, Schirren CA, Bittmann I, Dugas M, Reiser M. Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging. AJR Am J Roentgenol. 2002;179:1045-1051. [PMID: 12239063 DOI: 10.2214/ajr.179.4.1791045] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
53 Brown G. Imaging of the liver in metastatic disease. European Journal of Cancer Supplements 2003;1:159-71. [DOI: 10.1016/s1359-6349(03)90020-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
54 Menu Y, Bessoud B, Rocher L, Lesavre A, Phan C, Rangheard A. Lésions hépatiques en cancérologie générale. Journal de Radiologie 2007;88:1091-103. [DOI: 10.1016/s0221-0363(07)89921-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
55 Sofue K, Tsurusaki M, Miyake M, Sakurada A, Arai Y, Sugimura K. Detection of hepatic metastases by superparamagnetic iron oxide-enhanced MR imaging: prospective comparison between 1.5-T and 3.0-T images in the same patients. Eur Radiol. 2010;20:2265-2273. [PMID: 20428875 DOI: 10.1007/s00330-010-1798-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
56 Rief M, Wagner M, Franiel T, Bresan V, Taupitz M, Klessen C, Hamm B, Asbach P. Detection of focal liver lesions in unenhanced and ferucarbotran-enhanced magnetic resonance imaging: a comparison of T2-weighted breath-hold and respiratory-triggered sequences. Magnetic Resonance Imaging 2009;27:1223-9. [DOI: 10.1016/j.mri.2009.05.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
57 Ward J, Guthrie JA, Wilson D, Arnold P, Lodge JP, Toogood GJ, Wyatt JI, Robinson PJ. Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging--comparison of optimized sequences. Radiology. 2003;228:709-718. [PMID: 12888620 DOI: 10.1148/radiol.2283020376] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 3.6] [Reference Citation Analysis]
58 Zhang J, Li J, Razavi FS, Mumin AM. One-pot synthesis and characterization of rhodamine derivative-loaded magnetic core–shell nanoparticles. J Nanopart Res 2011;13:1909-16. [DOI: 10.1007/s11051-010-9942-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
59 Bajpai S, Sahani DV. Recent progress in imaging of colorectal cancer liver metastases. Curr colorectal cancer rep 2009;5:99-107. [DOI: 10.1007/s11888-009-0015-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
60 Ward J. New MR techniques for the detection of liver metastases. Cancer Imaging 2006;6:33-42. [PMID: 16766267 DOI: 10.1102/1470-7330.2006.0007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
61 McCann TE, Kosaka N, Turkbey B, Mitsunaga M, Choyke PL, Kobayashi H. Molecular imaging of tumor invasion and metastases: the role of MRI. NMR Biomed 2011;24:561-8. [PMID: 21793070 DOI: 10.1002/nbm.1590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
62 Hori M, Murakami T, Kim T, Tsuda K, Takahashi S, Okada A, Takamura M, Nakamura H. Detection of Hypervascular Hepatocellular Carcinoma: Comparison of SPIO-enhanced MRI With Dynamic Helical CT: . Journal of Computer Assisted Tomography 2002;26:701-10. [DOI: 10.1097/00004728-200209000-00007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
63 Zech CJ, Reiser MF. Radiological Evaluation of Patients with Liver Tumors. In: Bilbao JI, Reiser MF, editors. Liver Radioembolization with 90Y Microspheres. Berlin: Springer Berlin Heidelberg; 2008. pp. 15-28. [DOI: 10.1007/978-3-540-35423-9_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Wesolowski JR, Kaiser A. Alternatives to GBCA: Are We There Yet? Topics in Magnetic Resonance Imaging 2016;25:171-5. [DOI: 10.1097/rmr.0000000000000096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
65 Kim YK, Kwak HS, Han YM, Kim CS. Usefulness of Combining Sequentially Acquired Gadobenate Dimeglumine-Enhanced Magnetic Resonance Imaging and Resovist-Enhanced Magnetic Resonance Imaging for the Detection of Hepatocellular Carcinoma: Comparison With Computed Tomography Hepatic Arteriography and Computed Tomography Arterioportography Using 16-Slice Multidetector Computed Tomography. Journal of Computer Assisted Tomography 2007;31:702-11. [DOI: 10.1097/rct.0b013e31802d0b6b] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
66 Lartigue L, Innocenti C, Kalaivani T, Awwad A, Sanchez Duque MDM, Guari Y, Larionova J, Guérin C, Montero JG, Barragan-montero V, Arosio P, Lascialfari A, Gatteschi D, Sangregorio C. Water-Dispersible Sugar-Coated Iron Oxide Nanoparticles. An Evaluation of their Relaxometric and Magnetic Hyperthermia Properties. J Am Chem Soc 2011;133:10459-72. [DOI: 10.1021/ja111448t] [Cited by in Crossref: 189] [Cited by in F6Publishing: 166] [Article Influence: 17.2] [Reference Citation Analysis]
67 Filippone A, Cianci R, Patriarca G, Sabatino F, Tartaro A, Cotroneo AR. The role of hepatocyte-specific staining in liver pathology. Expert Rev Gastroenterol Hepatol 2011;5:353-63. [PMID: 21651353 DOI: 10.1586/egh.11.32] [Reference Citation Analysis]
68 Kanematsu M, Kondo H, Goshima S, Kato H, Tsuge U, Hirose Y, Kim MJ, Moriyama N. Imaging liver metastases: review and update. Eur J Radiol 2006;58:217-28. [PMID: 16406434 DOI: 10.1016/j.ejrad.2005.11.041] [Cited by in Crossref: 93] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
69 Klippenstein DL, Lamonica DM. Preoperative imaging for metastasectomy. Surg Oncol Clin N Am 2007;16:471-92, vii. [PMID: 17606189 DOI: 10.1016/j.soc.2007.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
70 Pesapane F, Downey K, Rotili A, Cassano E, Koh DM. Imaging diagnosis of metastatic breast cancer. Insights Imaging 2020;11:79. [PMID: 32548731 DOI: 10.1186/s13244-020-00885-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
71 Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, Caralt T, Ayuso JR, Solé M, Sanchez M. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology. 2003;38:1034-1042. [PMID: 14512891 DOI: 10.1002/hep.1840380430] [Cited by in Crossref: 297] [Cited by in F6Publishing: 162] [Article Influence: 15.6] [Reference Citation Analysis]
72 Kim MJ, Kim JH, Choi JY, Park SH, Chung JJ, Kim KW, Mitchell DG. Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions. AJR Am J Roentgenol 2006;187:W255-66. [PMID: 16928903 DOI: 10.2214/AJR.05.0706] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
73 Santoro L, Grazioli L, Filippone A, Grassedonio E, Belli G, Colagrande S. Resovist enhanced MR imaging of the liver: Does quantitative assessment help in focal lesion classification and characterization? J Magn Reson Imaging 2009;30:1012-20. [DOI: 10.1002/jmri.21937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
74 Schima W, Kulinna C, Langenberger H, Ba-Ssalamah A. Liver metastases of colorectal cancer: US, CT or MR? Cancer Imaging. 2005;5 Spec No A:S149-S156. [PMID: 16361131 DOI: 10.1102/1470-7330.2005.0035] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 3.3] [Reference Citation Analysis]
75 Cresswell AB, Welsh FK, Rees M. A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy? HPB (Oxford). 2009;11:533-540. [PMID: 20495704 DOI: 10.1111/j.1477-2574.2009.00081.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
76 Kim HJ, Kim KW, Byun JH, Won HJ, Shin YM, Kim PN, Lee MS, Lee MG. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. AJR Am J Roentgenol. 2006;186:1059-1066. [PMID: 16554579 DOI: 10.2214/ajr.04.1941] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
77 Suzuki H, Tsurita G, Ishihara S, Akahane M, Kitayama J, Nagawa H. Resovist-enhanced MRI for preoperative assessment of colorectal hepatic metastases: a case of multiple bile duct hamartomas associated with colon cancer. Case Rep Gastroenterol 2008;2:509-16. [PMID: 21897808 DOI: 10.1159/000183536] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
78 Arbab AS, Ichikawa T, Sou H, Araki T, Nakajima H, Ishigame K, Yoshikawa T, Kumagai H. Ferumoxides-enhanced Double-Echo T2-weighted MR Imaging in Differentiating Metastases from Nonsolid Benign Lesions of the Liver. Radiology 2002;225:151-8. [DOI: 10.1148/radiol.2251011090] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
79 Frate CD, Zuiani C, Londero V, Como G, Bazzocchi M, Mortele K, Ros PR. Comparing Levovist-Enhanced Pulse Inversion Harmonic Imaging and Ferumoxides-Enhanced MR Imaging of Hepatic Metastases. American Journal of Roentgenology 2003;180:1339-46. [DOI: 10.2214/ajr.180.5.1801339] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
80 Ward J, Robinson PJ, Guthrie JA, Downing S, Wilson D, Lodge JP, Prasad KR, Toogood GJ, Wyatt JI. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology. 2005;237:170-180. [PMID: 16126930 DOI: 10.1148/radiol.2371041444] [Cited by in Crossref: 118] [Cited by in F6Publishing: 97] [Article Influence: 6.9] [Reference Citation Analysis]
81 Morana G, Grazioli L, Testoni M, Caccia P, Procacci C. Contrast Agents for Hepatic Magnetic Resonance Imaging: . Topics in Magnetic Resonance Imaging 2002;13:117-50. [DOI: 10.1097/00002142-200206000-00002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
82 Hong HS, Byun JH, Won HJ, Kim KW, Lee SS, Lee MG, Yun SC. Characterization of liver metastases: the efficacy of biphasic magnetic resonance imaging with ferucarbotran-enhancement. Clin Radiol 2010;65:701-7. [PMID: 20696297 DOI: 10.1016/j.crad.2010.04.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
83 Ward J, Robinson PJ. COMBINED USE OF MR CONTRAST AGENTS FOR EVALUATING LIVER DISEASE. Magnetic Resonance Imaging Clinics of North America 2001;9:767-83. [DOI: 10.1016/s1064-9689(21)00273-7] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
84 Kim JH, Kim MJ, Suh SH, Chung JJ, Yoo HS, Lee JT. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times. J Magn Reson Imaging 2002;15:573-83. [PMID: 11997899 DOI: 10.1002/jmri.10102] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
85 Yousaf MZ, Yu J, Hou Y, Gao S. Magnetic nanoparticle-based cancer nanodiagnostics. Chinese Phys B 2013;22:058702. [DOI: 10.1088/1674-1056/22/5/058702] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
86 Kim YK, Lee JM, Kim CS. Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 2004;14:5-13. [PMID: 14600778 DOI: 10.1007/s00330-003-2115-1] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 3.7] [Reference Citation Analysis]
87 Engelen SM, Beets GL, Beets-tan RG. Role of Preoperative Local and Distant Staging in Rectal Cancer. Oncol Res Treat 2007;30:141-5. [DOI: 10.1159/000099026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
88 Lee IJ, Kim SH, Kim DS, Lee JM, Han JK, Choi BI. Intrahepatic extramedullary hematopoiesis mimicking a hypervascular hepatic neoplasm on dynamic- and SPIO-enhanced MRI. Korean J Radiol 2008;9 Suppl:S34-8. [PMID: 18607123 DOI: 10.3348/kjr.2008.9.s.s34] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
89 Yezhelyev M, Yacoub R, O’regan R. Inorganic nanoparticles for predictive oncology of breast cancer. Nanomedicine 2009;4:83-103. [DOI: 10.2217/17435889.4.1.83] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
90 Scharitzer M, Ba-Ssalamah A, Ringl H, Kölblinger C, Grünberger T, Weber M, Schima W. Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur Radiol. 2013;23:2187-2196. [PMID: 23519439 DOI: 10.1007/s00330-013-2824-z] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 8.0] [Reference Citation Analysis]
91 Kim SJ, Kim SH, Lee J, Chang S, Kim Y, Kim SH, Jeon YH, Choi D. Ferucarbotran-Enhanced 3.0-T Magnetic Resonance Imaging Using Parallel Imaging Technique Compared With Triple-Phase Multidetector Row Computed Tomography for the Preoperative Detection of Hepatocellular Carcinoma: . Journal of Computer Assisted Tomography 2008;32:379-85. [DOI: 10.1097/rct.0b013e3180de5c80] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
92 Tanimoto A, Kuribayashi S. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol 2006;58:200-16. [PMID: 16414230 DOI: 10.1016/j.ejrad.2005.11.040] [Cited by in Crossref: 100] [Cited by in F6Publishing: 83] [Article Influence: 6.3] [Reference Citation Analysis]
93 Oh J, Feldman MD, Kim J, Condit C, Emelianov S, Milner TE. Detection of magnetic nanoparticles in tissue using magneto-motive ultrasound. Nanotechnology 2006;17:4183-90. [DOI: 10.1088/0957-4484/17/16/031] [Cited by in Crossref: 130] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
94 Cha HG, Kim CW, Kang SW, Kim BK, Kang YS. Preparation and Characterization of the Magnetic Fluid of Trimethoxyhexadecylsilane-Coated Fe 3 O 4 Nanoparticles. J Phys Chem C 2010;114:9802-7. [DOI: 10.1021/jp912166b] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
95 Schima W, Stadler A. Hepatic Metastases: Diagnostic Imaging*). European Surg 2002;34:319-25. [DOI: 10.1046/j.1563-2563.2002.t01-1-02076.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
96 Pan D, Lanza GM, Wickline SA, Caruthers SD. Nanomedicine: perspective and promises with ligand-directed molecular imaging. Eur J Radiol 2009;70:274-85. [PMID: 19268515 DOI: 10.1016/j.ejrad.2009.01.042] [Cited by in Crossref: 75] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
97 Kumano S, Murakami T, Kim T, Hori M, Okada A, Sugiura T, Noguchi Y, Kawata S, Tomoda K, Nakamura H. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions. AJR Am J Roentgenol 2003;181:1335-9. [PMID: 14573430 DOI: 10.2214/ajr.181.5.1811335] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
98 Park JM, Kim IY, Kim SW, Lee SM, Kim HG, Kim SY, Shin HC. A comparative study of FDG PET/CT and enhanced multi-detector CT for detecting liver metastasis according to the size and location. Ann Nucl Med 2013;27:217-24. [PMID: 23242953 DOI: 10.1007/s12149-012-0677-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
99 Hultman KL, Raffo AJ, Grzenda AL, Harris PE, Brown TR, O'Brien S. Magnetic resonance imaging of major histocompatibility class II expression in the renal medulla using immunotargeted superparamagnetic iron oxide nanoparticles. ACS Nano 2008;2:477-84. [PMID: 19206573 DOI: 10.1021/nn700400h] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 4.8] [Reference Citation Analysis]
100 Mazumdar M, Liu A. Group sequential design for comparative diagnostic accuracy studies. Statist Med 2003;22:727-39. [DOI: 10.1002/sim.1386] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
101 Kim T, Murakami T, Hori M, Onishi H, Tomoda K, Nakamura H. Effect of superparamagnetic iron oxide on tumor-to-liver contrast at T2*-weighted gradient-echo MRI: comparison between 3.0T and 1.5T MR systems. J Magn Reson Imaging 2009;29:595-600. [PMID: 19243054 DOI: 10.1002/jmri.21384] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
102 Tanimoto A. Use of SPIOs for Clinical Liver Imaging. In: Bulte JW, Modo MM, editors. Nanoparticles in Biomedical Imaging. New York: Springer; 2008. pp. 41-61. [DOI: 10.1007/978-0-387-72027-2_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Lee DH, Kim SH, Lee JM, Park HS, Lee JY, Yi NJ, Suh KS, Jang JJ, Han JK, Choi BI. Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on milan criteria: correlation with histopathological findings. Invest Radiol 2009;44:311-21. [PMID: 19462486 DOI: 10.1097/rli.0b013e31819c9f44] [Cited by in Crossref: 32] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
104 Moghadam FF. Using Nanoparticles in Medicine for Liver Cancer Imaging. Oman Med J 2017;32:269-74. [PMID: 28804578 DOI: 10.5001/omj.2017.54] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
105 Okada T, Sasaki F, Kamiyama T, Nakagawa T, Nakanishi K, Kobayashi R, Itoh T, Ota S, Todo S. Focal nodular hyperplasia of the liver: usefulness of superparamagnetic iron oxide–enhanced magnetic resonance imaging. Journal of Pediatric Surgery 2005;40:E21-5. [DOI: 10.1016/j.jpedsurg.2004.11.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
106 Ward J, Guthrie JA, Sheridan MB, Boyes S, Smith JT, Wilson D, Wyatt JI, Treanor D, Robinson PJ. Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases. J Clin Oncol. 2008;26:4304-4310. [PMID: 18779617 DOI: 10.1200/jco.2008.16.1893] [Cited by in Crossref: 62] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
107 Tsurusaki M, Sugimoto K, Fujii M, Fukuda T, Matsumoto S, Sugimura K. Combination of CT during arterial portography and double-phase CT hepatic arteriography with multi-detector row helical CT for evaluation of hypervascular hepatocellular carcinoma. Clinical Radiology 2007;62:1189-97. [DOI: 10.1016/j.crad.2007.05.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
108 Lencioni R, Pina CD, Bruix J, Majno P, Grazioli L, Morana G, Filippone A, Laghi A, Bartolozzi C. Clinical Management of Hepatic Malignancies: Ferucarbotran-Enhanced Magnetic Resonance Imaging Versus Contrast-Enhanced Spiral Computed Tomography. Dig Dis Sci 2005;50:533-7. [DOI: 10.1007/s10620-005-2469-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
109 Namkung S, Zech CJ, Helmberger T, Reiser MF, Schoenberg SO. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions. J Magn Reson Imaging 2007;25:755-65. [PMID: 17335040 DOI: 10.1002/jmri.20873] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
110 Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology. 2005;237:520-528. [PMID: 16192317 DOI: 10.1148/radiol.2372041183] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
111 Onishi H, Murakami T, Kim T, Hori M, Iannaccone R, Kuwabara M, Abe H, Nakata S, Osuga K, Tomoda K, Passariello R, Nakamura H. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 2006;239:131-8. [PMID: 16484347 DOI: 10.1148/radiol.2383041825] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
112 Uggowitzer MM. What is the current situation in liver imaging? Eur Radiol 2003;13:N65-9. [DOI: 10.1007/s00330-003-0010-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
113 Fraile Moreno E, Cruz Díaz A. [Diagnostic imaging in liver pathology]. Rev Clin Esp 2005;205:97-8. [PMID: 15811274 DOI: 10.1157/13072963] [Reference Citation Analysis]
114 Heilmaier C, Lutz AM, Bolog N, Weishaupt D, Seifert B, Willmann JK. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging. Radiology 2009;253:724-33. [PMID: 19789232 DOI: 10.1148/radiol.2533090161] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
115 Low RN. Abdominal MRI advances in the detection of liver tumours and characterisation. Lancet Oncol. 2007;8:525-535. [PMID: 17540304 DOI: 10.1016/S1470-2045(07)70170-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
116 Boozari B, Lotz J, Galanski M, Gebel M. Diagnostic imaging of liver tumours. Current status. Internist (Berl). 2007;48:8, 10-2, 14-6, 18-20. [PMID: 17216509 DOI: 10.1007/s00108-006-1773-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
117 Savranoglu P, Obuz F, Karasu S, Coker A, Secil M, Sagol O, Igci E, Dicle O, Astarcioglu I. The role of SPIO-enhanced MRI in the detection of malignant liver lesions. Clin Imaging 2006;30:377-81. [PMID: 17101405 DOI: 10.1016/j.clinimag.2006.06.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
118 Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol. 2010;45:133-141. [PMID: 20098330 DOI: 10.1097/rli.0b013e3181caea5b] [Cited by in Crossref: 164] [Cited by in F6Publishing: 53] [Article Influence: 13.7] [Reference Citation Analysis]
119 Oh J, Feldman MD, Kim J, Kang HW, Sanghi P, Milner TE. Magneto-motive detection of tissue-based macrophages by differential phase optical coherence tomography. Lasers Surg Med 2007;39:266-72. [PMID: 17295337 DOI: 10.1002/lsm.20473] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
120 Cai W, Chen X. Nanoplatforms for Targeted Molecular Imaging in Living Subjects. Small 2007;3:1840-54. [DOI: 10.1002/smll.200700351] [Cited by in Crossref: 403] [Cited by in F6Publishing: 353] [Article Influence: 26.9] [Reference Citation Analysis]
121 Elsayes KM, Leyendecker JR, Menias CO, Oliveira EP, Narra VR, Chapman WC, Hassanien MH, Elsharkawy MS, Brown JJ. MRI characterization of 124 CT-indeterminate focal hepatic lesions: evaluation of clinical utility. HPB (Oxford) 2007;9:208-15. [PMID: 18333224 DOI: 10.1080/13651820701216950] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
122 Schnorr J, Wagner S, Abramjuk C, Drees R, Schink T, Schellenberger EA, Pilgrimm H, Hamm B, Taupitz M. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits. Radiology 2006;240:90-100. [PMID: 16684917 DOI: 10.1148/radiol.2393040884] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
123 Kim MJ, Kim JH, Chung JJ, Park MS, Lim JS, Oh YT. Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging. Radiology. 2003;228:719-726. [PMID: 12881583 DOI: 10.1148/radiol.2283020735] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 3.1] [Reference Citation Analysis]
124 Cheng W, Ping Y, Zhang Y, Chuang KH, Liu Y. Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis. J Healthc Eng 2013;4:23-45. [PMID: 23502248 DOI: 10.1260/2040-2295.4.1.23] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
125 Kim YK, Kwak HS, Kim CS, Chung GH, Han YM, Lee JM. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology 2006;238:531-41. [PMID: 16371577 DOI: 10.1148/radiol.2381042193] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]